Jun 25, 2018 12:08pm EDT CohBar Presents Preclinical Data on Mechanism of Action for its Lead Candidate, CB4211, at American Diabetes Association 78th Scientific Sessions
Jun 06, 2018 9:45am EDT CohBar to Hold 2018 Annual Shareholder Meeting and Investor Update, June 19, 2018
May 29, 2018 9:00am EDT CohBar to Present CB4211 Novel Mechanism of Action at American Diabetes Association 78th Scientific Sessions
Apr 13, 2018 4:05pm EDT CohBar, Inc. Announces Closing of Private Placement for Aggregate Gross Proceeds of Approximately $3,900,000
Mar 26, 2018 9:00am EDT CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes